Clinical Trial Update: (+) Epicatechin to Treat Friedreich's Ataxia [Phase 2]

View source ↗

Summary

Phase 2 trial investigating epicatechin for Friedreich's ataxia has completed with results posted.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Friedreich Ataxia

Drugs mentioned

• Epicatechin ((-)-Epicatechin)

Snippet

Sponsor: Ralitza Gavrilova | Conditions: Friedreich's Ataxia | Phase 2 | Status: COMPLETED | Results posted: 2019-12-05